Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR mHealth and uHealth

Date Submitted: Feb 20, 2026
Open Peer Review Period: Feb 23, 2026 - Apr 20, 2026
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

User Engagement and Feature Preferences in an AI-powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial

  • Benjamin Lalani; 
  • Gabriela Siew; 
  • Yllka Valdez; 
  • Aliyah Shehadeh; 
  • Daniel Zade; 
  • Kristin Riekert; 
  • Nestoras Mathioudakis

ABSTRACT

Background:

Prediabetes is highly prevalent and increasing globally, yet lifestyle interventions remain underutilized. Artificial intelligence (AI)-driven mobile health tools can help scale diabetes prevention efforts, but the key factors driving their success are not well understood.

Objective:

This prospective study aims to characterize the most valued features and the role of user engagement on outcomes in a fully automated mHealth intervention for diabetes prevention.

Methods:

Data from 151 participants with prediabetes and overweight or obesity assigned an AI-based Diabetes Prevention Program (Sweetch, Sweetch Ltd.) in a parent RCT (NCT05056376) were analyzed. Engagement (defined as total days where app was used) was categorized into tertiles (low, medium, high). Baseline characteristics were compared across engagement groups using ANOVA, Kruskal-Wallis, and chi-square tests, and regression models assessed the association between engagement and achievement of diabetes risk reduction outcomes (≥5% weight loss, ≥4% weight loss with ≥150 min/week of activity, or ≥0.2-point A1C reduction at 12 months). Perceived usefulness of intervention features was surveyed at 12 months.

Results:

At 12 months, median engagement was 98 days (IQR: 34–232), with most participants (75.5%) demonstrating a decreasing engagement trajectory over time. Older age (p < 0.001) and lower baseline BMI (p < 0.05) were significantly associated with higher engagement. High engagement was significantly associated with achieving the composite diabetes risk reduction outcome (OR: 2.59; 95% CI: 1.11–6.01), ≥5% weight loss (OR: 3.31; 95% CI: 1.16–9.42), and ≥0.2% A1C reduction (OR: 3.57; 95% CI: 1.19–10.75) compared to low engagement. The app features perceived most useful in achieving participant health goals were weight tracking, activity tracking, and the digital scale.

Conclusions:

Higher engagement with an AI-driven intervention requiring no human intervention was associated with improved diabetes risk reduction. Contrary to concerns about lower digital literacy, older adults engaged with the intervention the most. Features related to weight and physical activity tracking were most valued by patients in the program. Clinical Trial: ClinicalTrials.gov Identifier: NCT05056376


 Citation

Please cite as:

Lalani B, Siew G, Valdez Y, Shehadeh A, Zade D, Riekert K, Mathioudakis N

User Engagement and Feature Preferences in an AI-powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial

JMIR Preprints. 20/02/2026:92981

DOI: 10.2196/preprints.92981

URL: https://preprints.jmir.org/preprint/92981

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.